Basic Information
Evenity
Regulatory Information
EMEA/H/C/004465
Authorised
December 9, 2019
8
May 7, 2025
Company Information
Belgium
Allée de la Recherche 60 B-1070 Bruxelles
UCB-Pharma SA
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Evenity is indicated in treatment of severe osteoporosis in postmenopausal women at high risk of fracture.
Overview Summary
Evenity is a medicine used to treat osteoporosis, a disease that makes bones fragile. It is for use in women who have been through the menopause and who have severe osteoporosis (low bone density and previous fracture), leading to a high risk of further fractures.